UPDATE : Monday, February 17, 2020
Biopharma stocks listed in H1 perform poorer than non-pharma peers by Nam Doo-hyun 2018-07-03 15:08
‘Government support for dementia tests might be ill-timed’ by Nam Doo-hyun 2018-07-03 11:47
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’ by Nam Doo-hyun 2018-07-02 16:47
BMS Korea wins fight for Eliquis patent by Nam Doo-hyun 2018-06-29 14:41
Prognostic marker for childhood obesity complications wins patent by Nam Doo-hyun 2018-06-27 12:19
Antarctic sea microorganisms; a solution to blood shortage? by Nam Doo-hyun 2018-06-26 14:44
Korea’s drug exports to US, Europe on the rise by Nam Doo-hyun 2018-06-25 16:09
Chong Kun Dang topped in H1 clinical trial by Nam Doo-hyun 2018-06-21 11:11
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit by Nam Doo-hyun 2018-06-19 11:43
‘Medytox botulinum toxin worth 600 billion won in China’ by Nam Doo-hyun 2018-06-19 09:26
Will SGLT-2 inhibitors win more antidiabetic prescriptions? by Nam Doo-hyun 2018-06-15 11:58
Highlights of US cancer meet: immunotherapy, gastrointestinal cancer by Nam Doo-hyun 2018-06-14 15:51
Dongkook, Chong Kun Dang most popular in functional foods by Nam Doo-hyun 2018-06-12 11:19
Drugmakers unveil new clinical data at US cancer meet by Nam Doo-hyun 2018-06-08 14:41
Gilead successfully switches HIV drug to Genvoya by Nam Doo-hyun 2018-06-07 15:11
‘Tug-of-war in Lipiodol pricing only hurts patients’ by Nam Doo-hyun 2018-06-05 15:23
‘Baxter’s Theranova dialyzer better than conventional devices’ by Nam Doo-hyun 2018-05-30 14:29
Korea to review cost-effectiveness of PCV of Pfizer, GSK by Nam Doo-hyun 2018-05-25 15:59
Korea exported drugs to Europe the most in first 4 months by Nam Doo-hyun 2018-05-24 15:31
Reyon’s suit against ViroMed dismissed over VM202 rights by Nam Doo-hyun 2018-05-24 11:38
Back to Top